Healthcare provider profile · identity verified

Lusine Soghbatyan

Internal Medicine · LOS ANGELES, CA · NPI 1174769145

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Metoprolol Succinate	Metoprolol Succinate	251	50
Atorvastatin Calcium	Atorvastatin Calcium	217	57
Cefdinir	Cefdinir	201	77
Metformin Hcl	Metformin Hcl	201	33
Pantoprazole Sodium	Pantoprazole Sodium	190	54
Gabapentin	Gabapentin	176	38
Losartan Potassium	Losartan Potassium	174	39
Amlodipine Besylate	Amlodipine Besylate	158	48
Torsemide	Torsemide	154	35
Jardiance	Empagliflozin	149	33
Rosuvastatin Calcium	Rosuvastatin Calcium	139	31
Farxiga	Dapagliflozin Propanediol	134	27
Hydralazine Hcl	Hydralazine Hcl	130	40
Furosemide	Furosemide	124	20
Fluticasone Propionate	Fluticasone Propionate	112	38
Tamsulosin Hcl	Tamsulosin Hcl	107	30
Levothyroxine Sodium	Levothyroxine Sodium	105	20
Ozempic	Semaglutide	104	20
Doxycycline Hyclate	Doxycycline Hyclate	103	51
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	103	20
Tradjenta	Linagliptin	97	23
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	96	49
Linzess	Linaclotide	95	33
Humalog Kwikpen U-100	Insulin Lispro	94	18
Lokelma	Sodium Zirconium Cyclosilicate	94	30
Metronidazole	Metronidazole	93	51
Mupirocin	Mupirocin	92	45
Nifedipine Er	Nifedipine	89	17
Lisinopril	Lisinopril	81	18
Omeprazole	Omeprazole	76	16
Memantine Hcl	Memantine Hcl	65	18
Rybelsus	Semaglutide	63	13
Buspirone Hcl	Buspirone Hcl	62	13
Midodrine Hcl	Midodrine Hcl	62	20
Clopidogrel	Clopidogrel Bisulfate	60	12
Meclizine Hcl	Meclizine Hcl	60	20
Sucralfate	Sucralfate	59	28
Valacyclovir	Valacyclovir Hcl	59	29
Isosorbide Dinitrate	Isosorbide Dinitrate	58	16
Ranolazine Er	Ranolazine	55	14
Latanoprost	Latanoprost	51	11
Carafate	Sucralfate	50	27
Eliquis	Apixaban	49	13
Dutasteride	Dutasteride	46	14
Trazodone Hcl	Trazodone Hcl	45	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	44	19
Ofloxacin	Ofloxacin	43	24
Rena-Vite Rx	Vit B Comp No.3/Folic/C/Biotin	43	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	42	suppressed
Carvedilol	Carvedilol	41	suppressed
Fosfomycin Tromethamine	Fosfomycin Tromethamine	41	18
Digoxin	Digoxin	39	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	39	21
Lactulose	Lactulose	38	suppressed
Xarelto	Rivaroxaban	38	suppressed
Alendronate Sodium	Alendronate Sodium	37	12
Ketoconazole	Ketoconazole	37	15
Entresto	Sacubitril/Valsartan	35	suppressed
Ezetimibe	Ezetimibe	35	15
Nystatin	Nystatin	35	22
Cephalexin	Cephalexin	34	27
Nystop	Nystatin	34	suppressed
Trulicity	Dulaglutide	34	suppressed
Sertraline Hcl	Sertraline Hcl	33	11
Metoprolol Tartrate	Metoprolol Tartrate	32	11
Dexilant	Dexlansoprazole	31	suppressed
Duloxetine Hcl	Duloxetine Hcl	31	suppressed
Famotidine	Famotidine	29	suppressed
Folic Acid	Folic Acid	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	16
Atrovent Hfa	Ipratropium Bromide	27	14
Lidocaine	Lidocaine	27	11
Clotrimazole	Clotrimazole	26	13
Metolazone	Metolazone	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Restasis	Cyclosporine	26	suppressed
Kerendia	Finerenone	25	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	25	16
Spironolactone	Spironolactone	25	suppressed
Levofloxacin	Levofloxacin	24	16
Xifaxan	Rifaximin	24	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Azithromycin	Azithromycin	21	13
Baclofen	Baclofen	21	suppressed
Cinacalcet Hcl	Cinacalcet Hcl	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	21	14
Ursodiol	Ursodiol	21	suppressed
Erythromycin	Erythromycin Base	20	13
Jublia	Efinaconazole	20	suppressed
Alprazolam	Alprazolam	19	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	19	suppressed
Lialda	Mesalamine	19	suppressed
Freestyle Libre 3 Sensor	Blood-Glucose Sensor	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	11
Urea	Urea	18	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	17	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	17	12
Carvedilol Er	Carvedilol Phosphate	16	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Azulfidine	Sulfasalazine	15	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Amoxicillin	Amoxicillin	14	11
Diltiazem Hcl	Diltiazem Hcl	14	suppressed
Ciclopirox	Ciclopirox	13	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	13	suppressed
Insulin Lispro Junior Kwikpen	Insulin Lispro	13	suppressed
Mometasone Furoate	Mometasone Furoate	13	suppressed
Potassium Chloride	Potassium Chloride	13	suppressed
Restasis Multidose	Cyclosporine	13	suppressed
Simbrinza	Brinzolamide/Brimonidine Tart	13	suppressed
Tramadol Hcl	Tramadol Hcl	13	suppressed
Alphagan P	Brimonidine Tartrate	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Peg-3350 And Electrolytes	Peg3350/Sod Sulf,bicarb,cl/Kcl	12	11
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Creon	Lipase/Protease/Amylase	11	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	11	suppressed
Exforge	Amlodipine Besylate/Valsartan	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Levemir Flexpen	Insulin Detemir	11	suppressed
Montelukast Sodium	Montelukast Sodium	11	suppressed
Prednisolone Acetate	Prednisolone Acetate	11	suppressed
Ramelteon	Ramelteon	11	suppressed
Sevelamer Hcl	Sevelamer Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error